Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
Work
Year: 2014
Type: article
Source: The Lancet Oncology
Authors Thierry Conroy, Marie‐Pierre Galais, Jean‐Luc Raoul, Olivier Bouché, S. Gourgou-Bourgade +12 more
Institutions Institut de Cancérologie de Lorraine, Université de Lorraine, Centre François Baclesse, Centre Eugène Marquis, Université de Reims Champagne-Ardenne +14 more
Cites: 38
Cited by: 383
Related to: 10
FWCI: 34.06
Citation percentile (by year/subfield): 100
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed